Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MPV 1248

Known as: MPV-1248 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
To investigate the usefulness of atipamezole [MPV-1248, 4-(2-ethyl-2, 3-dihydro-1H-inden-2-yl)-1H-imidazole], a novel alpha(2… Expand
Is this relevant?
1992
1992
Atipamezole (MPV-1248, 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole), a potent alpha 2-adrenoceptor antagonist, was… Expand
Is this relevant?
1990
1990
1. Single doses (10, 30 and 100 mg) of atipamezole (MPV-1248), a new potent and selective imidazole-type alpha 2-adrenoceptor… Expand
Is this relevant?
1990
1990
The role of alpha 2-adrenoceptors in the regulation of basal prolactin secretion was investigated in healthy male volunteers. Two… Expand
Is this relevant?
Highly Cited
1989
Highly Cited
1989
The potency, selectivity and specificity of atipamezole [MPV-1248, 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole], as an… Expand
Is this relevant?
1989
1989
The anesthetic-reducing property of medetomidine far exceeds that seen with other alpha 2-adrenergic agonists (e.g., clonidine… Expand
Is this relevant?
1988
1988
The effects of antipamezole (MPV-1248), a novel selective and specific alpha 2-adrenoceptor antagonist, were studied on monoamine… Expand
Is this relevant?
1986
1986
 
Is this relevant?
1986
1986
The changes of free 3-methoxy-4-hydroxyphenylglycol (MHPG) in cerebrospinal fluid (CSF) were compared with the corresponding… Expand
Is this relevant?